What are the names of the BTK inhibitors?
What are the names of the approved drugs that inhibit Bruton's tyrosine kinase? What are they used to treat?
The Bruton's tyrosine kinase (BTK) inhibitors include Imbruvica (ibrutinib), Calquence (acalabrutinib), Brukinsa (zanubrutinib), and Jaypirca (pirtobrutinib).
Imbruvica (ibrutinib) Capsules, Tablets, and Oral Suspension
FDA Approved: November 13, 2013
Company: Janssen Biotech, Inc.
Treatment for adult patients with:
- Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).
- Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) with 17p deletion.
- Waldenström’s Macroglobulinemia (WM).
Treatment of adult and pediatric patients age 1 year and older with:
- Chronic Graft Versus Host Disease (cGVHD) after failure of one or more lines of systemic therapy.
Calquence (acalabrutinib) Capsules and Tablets
FDA Approved: October 31, 2017
Company: AstraZeneca
Treatment for adult patients with:
- Mantle Cell Lymphoma (MCL) who have received at least one prior therapy.
This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. - Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).
Brukinsa (zanubrutinib) Capsules
FDA Approved: November 14, 2019
Company: BeiGene, Ltd.
Treatment for adult patients with:
- Mantle Cell Lymphoma (MCL) who have received at least one prior therapy.
This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. - Waldenström’s Macroglobulinemia (WM).
- Marginal Zone Lymphoma (MZL) who have received at least one anti-CD20-based regimen.
This indication is approved under accelerated approval based on overall
response rate. Continued approval for this indication may be contingent upon
verification and description of clinical benefit in a confirmatory trial. - Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).
- Follicular Lymphoma (FL) (relapsed or refractory) in combination with obinutuzumab, after two or more lines of systemic therapy.
This indication is approved under accelerated approval based on response
rate and durability of response. Continued approval for this indication may
be contingent upon verification and description of clinical benefit in a
confirmatory trial.
Jaypirca (pirtobrutinib) Tablets
FDA Approved: January 27, 2023
Company: Eli Lilly and Company
Treatment for adult patients with:
- Mantle Cell Lymphoma (MCL) who have received at least two prior therapies, including a BTK inhibitor.
This indication is approved under accelerated approval based on response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. - Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) who have received at least two prior lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor.
This indication is approved under accelerated approval based on response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Related questions
Read next
Related medical questions
- Is Imbruvica a chemotherapy drug?
- Who makes Imbruvica?
- What is the success rate of Rituxan (rituximab) in patients with blood cancers?
- What is the difference between Truxima and Rituxan?
- Does Truxima make you gain weight?
- What is the success rate of Epkinly?
- What is the cost of Kymriah?
- What is Zydelig used for and how does it work?
- What is the difference between Rituxan and Rituxan Hycela?
- How is Rituxan Hycela administered?
- What type of drug is Copiktra?
- What type of drug is Yescarta (axicabtagene ciloleucel)?
- How will I feel after a Rituxan infusion?
- How long does it take for Rituxan to work?
- How does the drug Rituxan work?
- Is Venclexta (venetoclax) chemotherapy?
- How do you prepare for a Rituxan infusion?
- What causes infusion reactions to rituximab?
- How effective is Venclexta?
- How long do you take Venclexta for?
- Is Truxima a chemotherapy drug?
- How is Arzerra administered and how long to work?
- Is Zydelig a chemotherapy drug?
- What is Arzerra used for and how does it work?
- How is Bendeka different to Treanda?
- Who makes Leukeran, and where is it made?
- How does Venclexta work?
Drug information
Related support groups
- Ibrutinib (10 questions, 14 members)
- Imbruvica (8 questions, 37 members)
- Brukinsa (1 questions, 3 members)
- Calquence (1 questions, 3 members)
- Zanubrutinib (1 questions, 3 members)
- Follicular Lymphoma (12 questions, 15 members)
- Chronic Lymphocytic Leukemia (CLL) (24 questions, 57 members)
- Mantle Cell Lymphoma (7 questions, 9 members)